A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
This study is being done to evaluate the safety and efficacy of atrasentan in men with metastatic hormone-refractory prostate cancer.
Prostate Cancer
DRUG: Atrasentan
The primary objective of this study is to evaluate safety and efficacy as measured by time-to-disease progression
This study is being done to evaluate the safety and efficacy of atrasentan in men with metastatic hormone-refractory prostate cancer.